Knowledge Hub

​Global Lymphoma Drugs Market 2017-2021: Analysis, Trends, Market Demands, Segment And Forecast

Press Release   •   Aug 07, 2017 09:29 EDT

About Lymphoma Drugs Market

Lymphoma is a type of cancer that affects the immune system of the body. Specifically, it affects the lymphocytes, a type of white blood cell. The lymphocytes are part of the immune system and help the body to fight infections. The cancerous lymphocytes grow uncontrollably and collect in different portions of the body; lymph node can be one of the most common sites for lymphoma development. The lymph nodes are found throughout the body particularly in the groin, neck, and under the arms. Lymphoma can also develop in the deeper lymph nodes such as those in bone marrow and spleen. Very rarely this disease can start in other parts of the body such as stomach, breast, skin, brain, bowel, or liver.

Technavios analysts forecast the global lymphoma drugs market to grow at a CAGR of 8.02% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global lymphoma drugs market for 2017-2021. To calculate the market size, the report considers the sales from branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:




Get Sample copy of this Report @

Technavio's report, Global Lymphoma Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


F. Hoffmann-La Roche

Johnson & Johnson

Seattle Genetics

Other prominent vendors


Bristol-Myers Squibb

Gilead Sciences




Takeda Pharmaceuticals

Teva Pharmaceutical Industries

Market driver

Increase in industry-academia collaborations

For a full, detailed list, view our report

Market challenge

High cost of lymphoma treatment

For a full, detailed list, view our report

View Report @

Market trend

Increasing consolidation in the cancer treatment market

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2021 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

Market outline

Lymphoma disease overview

PART 05: Market Introduction

Market overview

Market size and forecast

Five forces analysis

PART 06: Pipeline landscape

PART 07: Market segmentation by disease type



Send An Enquiry Request @

PART 08: Geographical segmentation

Lymphoma drugs market in Americas

Lymphoma drugs market in EMEA

Lymphoma drugs market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

Market drivers

Market challenges

PART 11: Market trends

Increasing consolidation in the cancer treatment market

Development of rituximab resistance leading to the development of new therapies

Studies performed to understand the genetics of lymphoma cells

PART 12: Vendor landscape

Competitive scenario

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.